1. Academic Validation
  2. Heparin-binding EGF-like growth factor

Heparin-binding EGF-like growth factor

  • Biochim Biophys Acta. 1997 Dec 9;1333(3):F179-99. doi: 10.1016/s0304-419x(97)00024-3.
G Raab 1 M Klagsbrun
Affiliations

Affiliation

  • 1 Department of Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract

HB-EGF is a heparin-binding member of the EGF family that was initially identified in the conditioned medium of human macrophages. Soluble mature HB-EGF is proteolytically processed from a larger membrane-anchored precursor and is a potent mitogen and chemotactic factor for fibroblasts, smooth muscle cells but not endothelial cells. HB-EGF activates two EGF receptor subtypes, HER1 and HER4 and binds to cell surface HSPG. The transmembrane form of HB-EGF is a juxtacrine growth and adhesion factor and is uniquely the receptor for diphtheria toxin. HB-EGF gene expression is highly regulated, for example by cytokines, growth factors, and transcription factors such as MyoD. HB-EGF has been implicated as a participant in a variety of normal physiological processes such as blastocyst implantation and wound healing, and in pathological processes such as tumor growth, SMC hyperplasia and atherosclerosis.

Figures
Products